Security key
74006W108
- Security type / class
- Equity / COM
- Total 13F shares
- 117,074,007
- Total 13F value
- $134,632,828
- Share change
- +63,816,959
- Put/Call ratio
- 0%
- SEC-reported price per share
- $1.15
- Number of holders
- 77
- Value change
- +$76,073,172
- Number of buys
- 40
- Number of sells
- 56
Open additional details 1 more signal available
Report period
Q2 2023
Institutions
77
Top holders
10
PRAX full security history
Ownership snapshot
Full 13F holder table
Praxis Precision Medicines, Inc. SEC filings
Praxis Precision Medicines, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of PRAX - PRAXIS PRECISION MEDICINES I - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Clarus Lifesciences III, ...
Disclosed value leader
Clarus Lifesciences III, ...
Comparable rows
0/15
Latest evidence
31 Mar 2023
3/4/5
13F
Highest disclosed value: $123,282,606
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Clarus Lifesciences III, L.P. has the largest disclosed position value at $123.28M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Clarus Lifesciences III, L.P.'s linked filing trail.
Disclosed position value
Top 5
Clarus Lifesciences III, L.P.
$123.28M
Velan Capital Investment Manageme...
$4.19M
KINGDON CAPITAL MANAGEMENT, L.L.C.
$3.8M
Avidity Partners Management LP
$3.46M
BANK OF AMERICA CORP /DE/
$3.26M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Clarus Lifesciences III, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$123,282,606
4,894,109 shares
|
— | 12 May 2021 |
| Velan Capital Investment Management LP |
13F
Company
|
—
denominator unverified
|
$4,194,665
5,185,000 shares
|
— | 31 Mar 2023 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
Company
|
—
denominator unverified
|
$3,802,300
4,700,000 shares
|
— | 31 Mar 2023 |
| Avidity Partners Management LP |
13F
Company
|
—
denominator unverified
|
$3,463,895
4,281,700 shares
|
— | 31 Mar 2023 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
—
denominator unverified
|
$3,256,847
4,025,769 shares
|
— | 31 Mar 2023 |
| Verition Fund Management LLC |
13F
Company
|
—
denominator unverified
|
$2,396,529
2,962,335 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
77
Shares
117,074,007
Rows available
77
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
86
Q2 2023 holders
77
Holder diff
-9
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|